Skip to main content
. 2016 Jun 27;6:28431. doi: 10.1038/srep28431

Table 1. Baseline parameters of study participants according to the MetS status at follow-up.

Characteristic Male (n = 66)
Female (n = 87)
non-MetS MetS p non-MetS MetS p
N (%) 48 (72.7) 18 (27.3)   77 (88.5) 10 (11.5)  
Age (years) 51.1 ± 7.9 50.8 ± 7.2 0.899 51.6 ± 6.0 49.3 ± 5.7 0.261
Current/former smoke n(%) 21 (43.8) 4 (22.2) 0.187 22 (28.6) 4 (40.0) 0.707
Alcohol drinking n(%) 28 (58.3) 10 (55.6) 1.000 34 (44.2) 7 (70.0) 0.229
BMI (kg/m2) 23.4 ± 2.6 26.3 ± 2.9 0.000 23.1 ± 2.5 25.0 ± 2.6 0.036
WC (cm) 83.6 ± 7.5 91.7 ± 8.9 0.000 78.4 ± 6.5 83.7 ± 9.4 0.024
WHR 0.88 ± 0.05 0.92 ± 0.06 0.004 0.84 ± 0.05 0.86 ± 0.05 0.266
SBP (mmHg) 121.9 ± 13.5 124.3 ± 11.0 0.499 116.1 ± 12.5 121.1 ± 13.1 0.239
DBP (mmHg) 78.9 ± 8.6 81.5 ± 8.7 0.285 74.5 ± 8.4 80.0 ± 7.9 0.053
FPG (mmol/L) 5.20 ± 0.46 5.39 ± 0.39 0.120 5.26 ± 0.44 5.27 ± 0.32 0.937
2hPG (mmol/L) 5.75 ± 1.61 6.78 ± 1.45 0.020 6.93 ± 1.54 6.28 ± 0.95 0.197
FINS (mIU/L) 16.79 ± 11.11 11.13 ± 5.54 0.051 17.37 ± 6.38 15.83 ± 6.66 0.493
HbA1c (%) 5.55 ± 0.33 5.51 ± 0.51 0.687 5.81 ± 0.44 5.76 ± 0.44 0.747
Triglycerides (mmol/L) 1.1 (0.8–1.5) 1.4 (1.2–2.0) 0.025 1.1 (0.8–1.5) 1.4 (1.0–1.6) 0.353
Cholesterol (mmol/L) 4.73 ± 0.89 5.22 ± 1.01 0.058 5.11 ± 1.01 5.04 ± 0.87 0.846
HDL-c (mmol/L) 1.37 ± 0.30 1.28 ± 0.30 0.306 1.63 ± 0.41 1.38 ± 0.25 0.066
LDL-c (mmol/L) 2.92 ± 0.80 3.45 ± 0.73 0.017 3.03 ± 0.81 3.27 ± 0.74 0.366
ALT (U/L) 23 ± 12 32 ± 31 0.095 17 ± 8 20 ± 16 0.546
AST(U/L) 22 ± 8 26 ± 13 0.080 20 ± 6 21 ± 8 0.669
GGT (U/L) 31 ± 18 36 ± 14 0.321 21 ± 14 25 ± 17 0.422
Log(HOMA-IR) (units) 0.52 ± 0.29 0.36 ± 0.23 0.022 0.58 ± 0.16 0.53 ± 0.22 0.419
Subcutaneous fat (cm2) 108.83 ± 45.49 144.44 ± 43.21 0.006 171.63 ± 55.64 197.01 ± 54.05 0.177
Visceral fat (cm2) 68.92 ± 40.29 113.89 ± 61.75 0.001 54.35 ± 23.46 70.35 ± 25.43 0.048

BMI, body mass index; WC, waist circumference; WHR, waist-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; 2hPG, two-hour postprandial plasma glucose; FINS, fasting insulin; HDL-c, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; ALT, alanine aminotransferase; AST, aspartate transaminase; GGT, glutamyl transpeptidase.